Form 4: GoHealth CEO Vijay Kotte Reports Stock Transactions
SEC Form 4
GoHealth CEO Vijay Kotte reports the acquisition and disposal of Class A Common Stock, including shares withheld for tax obligations and a grant of restricted stock units.
Summary
- On April 1, 2025, Vijay Kotte, CEO of GoHealth, Inc., reported transactions involving Class A Common Stock.
- 24,611 shares were disposed of to satisfy tax withholding obligations related to the vesting of restricted stock units.
- These shares were sold at a price of $12.39.
- Kotte was also granted 185,000 restricted stock units, which vest in three equal annual installments starting April 1, 2026.
- Following these transactions, Kotte directly owns 967,603 shares of Class A Common Stock.
- This includes shares purchased under the Employee Stock Purchase Plan.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing primarily reports routine stock transactions related to executive compensation and tax obligations. There are no explicit positive or negative indicators for the company's performance.
Positives
- The grant of 185,000 restricted stock units to the CEO aligns his interests with the long-term performance of the company.
- The CEO's continued direct ownership of 967,603 shares demonstrates a significant stake in the company's success.
Future Outlook
The CEO's future stock ownership will be affected by the vesting of the 185,000 restricted stock units over the next three years, starting April 1, 2026.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The vesting of restricted stock units is a common practice to incentivize executives.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the CEO's stock ownership.
- Employees participating in the Employee Stock Purchase Plan are also stakeholders.
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Date of grant of 55,555 restricted stock units that vested, leading to tax obligations. |
| 06/30/2024 | Date of purchase of 1,909 shares under the Issuer's Employee Stock Purchase Plan. |
| 12/31/2024 | Date of purchase of 1 share under the Issuer's Employee Stock Purchase Plan. |
| 04/01/2025 | Date of the reported transactions: disposal of shares for tax obligations and grant of new restricted stock units. |
| 04/01/2026 | Date of the first annual installment vesting of the 185,000 restricted stock units. |
| 04/03/2025 | Date of signature on the Form 4 filing. |
Keywords
GoHealth, Vijay Kotte, GOCO, Stock Transactions, Form 4, Restricted Stock Units, Beneficial Ownership, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.